PropertyValue
?:definition
  • Molecular assay reagents intended to identify genetic variants associated with altered patient response to substance abuse pharmaceuticals (i.e., anti-addiction medications). Genetic variants at multiple loci have been associated with altered pharmacokinetics or pharmacodynamics of substance abuse pharmaceuticals. These reagents are intended to detect various types of genetic changes (e.g., deletions, duplications, insertions, substitutions) in multiple substance abuse pharmacogenetic loci simultaneously.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C4287270_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C4287270_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all